A self-contained disposable explosively actuated ampule for performing needleless percutaneous injection. The ampule comprises an outer shell enclosing an elongated inner chamber including a closed rear end containing a propellant charge, a tapered funnel-shaped forward end, and a scored sealing member hermetically sealing the chamber in the area of its funnel shaped end. A metered dose of fluid injectant is confined between the scored sealing member and a sealing plunger separating the injectant from the charge. The plunger is adapted for axial movement within the chamber and comprises a main body having sealing means thereabout which are compressed and tightened against the inner chamber wall, and having a tip portion projecting forwardly from the main body. Gas released at very high pressure by the charge drives the plunger in the chamber and pressurizes the fluid injectant, thereby causing the scored sealing member to rupture and enabling the fluid to be discharged from the chamber forward end. Simultaneously, the outer circumferential surface of the plunger tip sealingly abuts the inner peripheral surface of the chamber forward end. The sealing elements in the plunger main body are comprised of an annular feather-edge seal around the rear end of the plunger and annular sealing means about the axial main body of the plunger.

Patent
   4124024
Priority
Mar 03 1977
Filed
Mar 03 1977
Issued
Nov 07 1978
Expiry
Mar 03 1997
Assg.orig
Entity
unknown
129
3
EXPIRED
1. In a needleless hypodermic injector operable by propellant gas generated from the detonation of an explosive charge, a disposable ampule comprising:
an elongated casing having an axial bore therein, said bore including an inwardly tapered portion at one end of said casing terminating in a fine orifice through said casing;
a cavity in said casing containing a propellant charge and in communication with said bore at the opposite end of said casing;
a gas-operated piston slidably and sealingly mounted in said bore for sliding axial movement therein in the direction of said orifice upon detonation of said charge, said piston having a tip portion conforming closely to the inwardly tapered portion of said bore;
a rupturable sealing member positioned in said tapered portion of said bore nearer said orifice, and with said piston defining a chamber in said bore for a measured dose of injectant fluid, said sealing member including means adapted to rupture under pressure exerted by said fluid in response to axial movement of said piston upon detonation of said charge, and to retrovert and deform into an hermetic seal between the tip portion of said piston and the inwardly tapered portion of said bore.
2. The disposable ampule of claim 1, comprising sealing means on said piston providing an hermetic seal between said piston and the inner wall of said bore for preventing leakage of combustion products into said fluid containing chamber following detonation of said charge.
3. The disposable ampule of claim 2, wherein said piston comprises a main body having an outer wall conforming closely with the inner wall of said bore and having a shallow recess formed in the end thereof remote from said orifice, said recess having a rim defining a feather-edge seal between said piston and the inner wall of said bore.
4. The disposable ampule of claim 3, wherein said rim is adapted to be flared outwardly into sealing engagement with the inner wall of said bore by the high impulse of the propellant gas generated from the detonation of said charge.
5. The disposable ampule of claim 3, wherein the main body of said piston is provided with at least one O-ring sealing member.
6. The disposable ampule of claim 3, wherein the main body of said piston comprises at least one integrally formed peripheral seal conforming closely with the inner wall of said bore.
7. The disposable ampule of claim 1, wherein said inwardly tapered portion of said bore comprises a first inwardly tapered section adjacent said orifice, and a second inwardly tapered section in communication with said first section, extending outwardly of said first section.
8. The disposable ampule of claim 7, wherein said sealing member is positioned between said first and second inwardly tapered sections.
9. The disposable ampule of claim 1, wherein said inwardly tapered portion of said bore comprises a first truncated conical section adjacent said orifice, and a second truncated conical section in communication with said first section, extending outwardly of said first section.
10. The disposable ampule of claim 1, wherein said sealing member comprises rupturable scored membrane.
11. The disposable ampule of claim 1, wherein said sealing member is positioned in the inwardly tapered portion of said bore.
12. The disposable ampule of claim 1, wherein said casing comprises a hollow outer cylindrical shell of thermoplastic material, having a snugly fitting heat insulating glass liner defining the inner wall of said bore.
13. The disposable ampule of claim 1, comprising a measure dose of injectant fluid.

1. Field of the Invention

This invention relates to needleless hypodermic medicators for effecting subcutaneous and intramuscular injections of medicaments and the like into animate or inanimate bodies. More specifically, the invention relates to an improved medicator of the type wherein a high pressure, explosive actuated plunger is utilized to discharge a material quantity of injectant fluid from a disposable ampule.

2. Prior Art

Techniques have evolved for subcutaneous innoculations or other injections without the use of a hypodermic needle in which a metered dose of injectant is projected against the skin at such high pressures and velocity that it penetrates the skin. Typically in such apparatus gas is released at very high pressure from a suitable propellant charge, the gas operating a piston or plunger for generating the requisite pressure used to eject the medicament or the like through a fine orifice. The high pressure exerted ejects the medicament in a very fine stream or jet at high velocity, the kinetic energy of which causes the stream to enter the body.

Among this type of prior art devices are those adapted to be fitted with a unitary disposable ampule which contains a quantity of the selected medicament and is provided with a suitable explosive charge at one end, an orifice at its other end and the explosive actuated piston or plunger situated between the charge and the medicament. Under the impulse of combustion of the charge, the piston is forced down the ampule to expel the medicament from the orifice. Detonation of the charge is effected by a discrete reusable actuating unit containing a triggering and firing mechanism. The actuating unit also comprises a housing portion, typically in the form of a barrel, formed to receive the ampule. Such an injection system utilizing a reusable actuated unit for use with a disposable medicant or ampule of the type discussed hereintofore is, for example, disclosed in our co-pending patent application Ser. No. 730,421 filed 7 October 1976 and entitled "PYROTECHNICALLY POWERED NEEDLELESS INJECTOR."

With direct explosive actuation in a closed system where both the medicament and the explosive are loaded in the same capsule or ampule and where the explosively actuated force is generated and applied directly into the piston to expel the medicament from the orifice in the capsule, there has always been the danger of mutual contamination. Prior art attempts to prevent such contamination have not been fully effective, or have been commercially infeasible. To protect the medicament from any gas penetration upon combustion of the propellant charge, it has been proposed in the aforementioned copending application to provide one or a plurality of sealing O-ring members around the piston body. Although the provision of such a sealing arrangement for this type of directly actuated medicator has proved to be satisfactory in most instances, the high peak pressures, pressure surges and rapid pressure fluctuations inherent with this type of injector system, still tend to affect the overall sealing efficiency of the device.

The principal object of the subject invention is to provide a pyrotechnically charged needleless hypodermic injector having novel sealing structure enabling the device to maintain uniform sealing efficiency over a wide range of pressures.

To achieve its stated objective, and other objects which will become apparent, the subject invention provides a unitary disposable medicator ampule adapted to be fitted in an actuating unit and having loaded within its interior a metered dose of injectant fluid, a gas-producing pyrotechnic propellant charge, and a sealing plunger separating the explosive from the fluid. The latter incorporates novel sealing structure effectively sealing the plunger in the ampule housing and providing positive sealing action to prevent any contamination of the medicament contained in the ampule.

Another object of the invention is to provide a novel ampule for such an injector having an inner chamber enclosing the medicament and incorporating novel sealing structure for hermetically sealing the medicament within the chamber.

Another object is to provide a pyrotechnically operated needleless hypodermic instrument of improved construction with respect to safety, speed and ease of operation.

Still a further object is provision of a simple and improved medicator ampule for performing percutaneous injection painlessly.

Still a further object of the invention is to provide a needleless hypodermic medicator ampule utilizing a pyrotechnically generated force to effect the percutaneous injection of predetermined doses of medication at desired depths with convenience, reliability, and safety.

A further object is to provide a disposable device of such type which can be manufactured economically for mass distribution.

The structure and operation of the subject invention will become apparent to the reader upon consideration of the following detailed description of the preferred embodiments illustrated in the accompanying drawing in which:

FIG. 1 is a side sectional view of an ampule embodying the subject invention positioned in the muzzle of a typical injector, prior to discharge;

FIG. 2 is a side sectional view of the ampule and injector of FIG. 1 during detonation and discharge of injectant fluid from the ampule; and

FIG. 3 is a side sectional view through another pressure injection ampule embodying the invention.

Whenever possible, like numerals are used to designate the same or equivalent components in the several figures.

Referring now to the drawing and with attention initially directed to FIGS. 1 and 3, there is shown a preferred embodiment of the invention comprising a medicator ampule 10, an actuating unit generally referenced by the numeral 12 and including an ampule receiver in the form of an elongated barrel 14 and a firing mechanism in the form of a firing pin 16 having a tip 18.

The actuating unit may be such as disclosed in the aforementioned copending application Ser. No. 730,421.

The ampule 10 consists of an elongated body having an outer shell 20 of polypropylene, polyethylene, acrylic, polycarbonate, nylon, or similar suitable material. The generally dome-shaped forward end 22 of the ampule body is enclosed by a sterile cover 24, e.g., of the styrene type or other suitable material. The cover 24 is held in position on the ampule forward end 22 by means of an inner annular lip 26 retained in an annular groove 28 formed in forward end 22. A tab portion 30 integral with the cover 24 enables the latter to be removed quickly and easily.

The closed rear end of the ampule defines an extended head 32. The head contains an explosive primer or percussion cap 34 operatively connected to a deflagatory charge 36.

A closure 35 and retainer 37 of suitable materials are provided to protect primer 34 and charge 36, respectively.

The outer shell 20 is seen to enclose an inner chamber 38 having a glass liner 40. The forward end 42 of the chamber is tapered. The tapered forward end comprises first and second sections 44, 46, or truncated conical configuration. The extreme forward end of section 46 is configured with an axial aperture 48 terminating in a discharge orifice 50. During storage and transport of the medicator the cover 24 seals the orifice and aperture so as to prevent any contaminant from contacting them or entering the chamber.

Axially slidably disposed within the chamber 38 is a sealing plunger 52. The plunger comprises a main body 54, a rear end 56, and a tapered forward end or tip 58. The main body has an outer diameter chosen to correspond closely to the inner diameter of chamber 38 so as to provide a snug fit with the chamber's wall 40. Positive frictional and sealing contact between the plunger main body 54 and the chamber wall defined by the glass liner 40 is effected by sealing means 60 and 62. The sealing means 60 are in the form of an annular featheredge seal formed by the edge or rim defined by a concavity in the main body, e.g., a hemispherical recess 64 formed in the rear end 56 of the plunger main body 54. The sealing means 62 in the embodiment shown in FIG. 1 is in the form of a molded seal which sealingly abuts the wall of liner 40.

The tapered forward end or tip 58 comprises first and second sections 66, 68 shaped as conical frustums and closely co-responding to the inner peripheral sections 44, 46 of the chamber tapered forward end 42.

An additional sealing member in the form of a scored membrane 70, typically of silicone rubber, is provided to hermetically seal the chamber 38. As shown, the membrane 70 is located at the intersecting points of the conical walls of the sections 44 and 46.

A metered quantity of fluid injectant 72 is loaded and confined between the plunger forward tapered end and the membrane 70. Frictional contact between the plunger sealing members 60, 62 and the inner wall of the chamber's liner 40, on the one hand, and the fixedly secured membrane 70, on the other hand, thus prevent premature discharge of the injectant charge 72 from the ampule. Also, since the plunger and membrane are immobile prior to use, the charge 70 is in a state of pressure equilibrium within the ampule during storage and transport.

The region of bore 38 between the rear end 56 of the plunger and the forward end 74 of the ampule extended head 32 may be considered the pressure chamber 76 of the instrument.

In operation as shown in FIG. 2, the actuating unit 12 is activated by a triggering device, not shown, which releases the firing pin 16 with a force sufficiently high to drive its tip 18 through the closure 35 and into the primer 34, thereby detonating charge 36. The gases generated by the slow burning charge burst through retainer 37, fill and build up pressure within chamber 76, and drive plunger 52 into the tapered end 42 of the chamber. Under the thrust of plunger 52 the fluid charge 72 ruptures the scored membrane 70 and fills the foremost sections 46 and 48 of the chamber. As the fluid pressure rapidly increases, the medicament 72 is discharged from orifice 50 in a high-velocity stream with sufficient force to penetrate the skin 78.

The sustaining force of the expending combustion products drives the plunger 52 toward the end of its stroke, at which point the surfaces of sections 66, 68 of its tip 58 are in sealing engagement with the abutting inner surfaces of sections 44, 46 of the chamber forward end 42.

As shown in FIG. 2, an additional seal is provided between the plunger tip 58 and the chamber wall in the region 46 by the membrane 70, which as a result of penetration of the tip 58 is expanded forwardly into the region 46 of the chamber and compressed tightly between the abutting surfaces of the plunger tip and the chamber forward end.

It should be noted that under the impulse of combustion of the charge 36, the edge 60 of concavity or recess 64 is flared radially outwardly into tight sealing engagement with the chamber liner 40 in region 46 due to the extremely high explosively generated force exerted directly on the plunger rearward end 56. Such a sealing arrangement, per se, prevents the penetration of hot gases past the featheredge seal 60. Should this seal 60 fail and permit a minimal amount of gases in some manner to pass, such gases would be intercepted and restrained by the molded seal 62.

The sealing structure of the arrangement illustrated in FIG. 3 is substantially identical with that of FIGS. 1 and 2, except that the plunger does not employ molded sealing means 62. Instead, an annular frame or recess 78 is provided in the circumference of main body 54 of the plunger and an O-ring 80 is seated in the recess 78.

It will be appreciated that instead of a single molded seal member 62 as shown in FIG. 1 and 2, or a single O-ring seal as illustrated in FIG. 3, a plurality of such sealing means may be utilized and may, for example, be arranged about the plunger main body in parallel relation to each other.

By selectively varying the quantity, and other characteristics of propellant charge 36, the resiliency and frictional properties of the plunger 52 and sealing means 60, 62 and 80, the dimensions of the chamber 38 and ampule 10, and the size and design of orifice 50, the dosage, depth of penetration through the skin and various other injection parameters can readily be established at the time of manufacture.

With the medicator ampule described above, improved injector pressure-time characteristics are obtained because of the closed ballistic system provided between the propellant charge 36 and plunger 52. The initial pressure acting against the plunger is extremely high and thereafter falls gradually to an injection-sustaining pressure level adequate to discharge all of the ampule contents. The heat insulating liner 40 of glass material serves to sustain the injection-producing pressure level. Some evidence suggests that in the absence of such a liner, the terminal pressure would fall or chop too rapidly, causing fluctuations or pressure surges, which some patients experience as pain.

During manufacture of the medicator ampule described, the glass lining 40 is initially formed, in conventional manner, with an open rear end and an open ended conical frustum at its forward end. Subsequently the plunger 52 is loaded into the glass liner or housing and held at the desired depth. Then, the space forward of the plunger is filled with a metered dose of medicament or the like, and the scored membrane 70 is sealed over and across the open forward end of the glass liner. Thereafter, the outer shell 20, which is molded to conform closely to the glass liner, is slipped around the liner while hot from the mold. Shrinkage of the plastic shell on cooling insures tight fit. Finally, the sterile cover is placed in position over forward end 22.

Although the foregoing description relates to what are believed to be preferred embodiments, it is to be understood that those skilled in the art may make changes and modifications without departing from the spirit and scope of the invention as set forth in the appended claims.

Schwebel, Paul R., Friend, Manuel N.

Patent Priority Assignee Title
10071203, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
10076611, Feb 01 2005 kaleo, Inc. Medicament delivery device having an electronic circuit system
10099011, May 03 2005 PHARMAJET, INC. Needle-less injector and method of fluid delivery
10099023, Feb 01 2005 kaleo, Inc. Devices, systems and methods for medicament delivery
10105489, Feb 01 2005 kaleo, Inc. Medical injector with compliance tracking and monitoring
10183116, Jan 26 2011 kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
10226583, May 22 2012 kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
10238806, Jan 26 2011 kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
10258735, Feb 05 2007 kaleo, Inc. Apparatus and methods for self-administration of vaccines and other medicaments
10314977, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
10322238, Dec 13 2011 PHARMAJET, INC. Needle-free intradermal injection device
10335549, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
10342924, Jan 26 2011 kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
10463795, Aug 02 2011 Pharmajet Inc. Needle-free injection methods
10576206, Jun 30 2015 KALEO, INC Auto-injectors for administration of a medicament within a prefilled syringe
10688244, Dec 23 2016 KALEO, INC Medicament delivery device and methods for delivering drugs to infants and children
10695495, Mar 24 2015 KALEO, INC Devices and methods for delivering a lyophilized medicament
10737028, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
10796604, Feb 27 2007 kaleo, Inc. Medical injector simulation device and containers for storing delivery devices
10806863, Aug 29 2014 DAICEL CORPORATION Needleless syringe
10835673, Oct 31 2005 kaleo, Inc. Devices, systems, and methods for medicament delivery
10842938, Dec 23 2016 kaleo, Inc. Medicament delivery device and methods for delivering drugs to infants and children
10894130, Apr 10 2015 DAICEL CORPORATION Syringe
10918791, Dec 04 2006 kaleo, Inc. Devices, systems and methods for medicament delivery
10960155, Feb 01 2005 kaleo, Inc. Devices, systems and methods for medicament delivery
11039908, Jun 16 2015 MIE UNIVERSITY; DAICEL CORPORATION Needleless syringe and method for introducing DNA into injection target area using same
11154659, Dec 13 2011 Pharmajet Inc. Needle-free intradermal injection device
11167087, Aug 09 2019 KALEO, INC Devices and methods for delivery of substances within a prefilled syringe
11426520, Jan 26 2011 kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
11471603, Aug 02 2011 PHARMAJET, INC. Needle-free injector
11517674, Jun 30 2015 kaleo, Inc. Auto-injectors for administration of a medicament within a prefilled syringe
11590286, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
11771830, Dec 23 2016 kaleo, Inc. Medicament delivery device and methods for delivering drugs to infants and children
11878147, Nov 13 2006 Pharmajet Inc. Needle-less injector and method of fluid delivery
4680027, Dec 12 1985 DARDIN, FRANCIS E Needleless hypodermic injection device
4726594, Sep 22 1986 Drug injection system for use with an arrow
4913699, Mar 14 1988 NATIONAL MEDICAL PRODUCTS, INC , A CORP OF CA Disposable needleless injection system
4945050, Nov 13 1984 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
5024656, Aug 30 1988 DARDIN, FRANCIS E Gas-pressure-regulated needleless injection system
5036006, Nov 13 1984 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
5064413, Nov 09 1989 BIOJECT INC Needleless hypodermic injection device
5100792, Nov 13 1984 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
5135500, Oct 31 1989 MCKINLEY INFUSER, INC Self-driven pump device
5176642, Mar 11 1991 Mectra Labs, Inc. Vacuum powdered syringe
5312335, Nov 09 1989 BIOJECT INC , AN OR CORP Needleless hypodermic injection device
5346473, Feb 22 1993 UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Oxy-hydrogen propelled torpedo for introducing angioplasty guide wire
5503627, Nov 09 1989 Bioject, Inc. Ampule for needleless injection
5503628, Mar 15 1995 Jettek, Inc.; JETTEK, INC Patient-fillable hypodermic jet injector
5584825, Dec 01 1994 Isolyser Co., Inc. Closure delivery system
5672162, Dec 01 1994 Isolyser Co., Inc. Closure delivery system
5746714, Apr 05 1993 BIOJECT INC Air powered needleless hypodermic injector
5899879, Dec 19 1995 GENESIS MEDICAL TECHNOLOGIES, INC Spring-actuated needleless injector
5938637, Mar 14 1997 PATH Single-use medicine delivery unit for needleless hypodermic injector
5993412, May 19 1997 BIOJECT, INC Injection apparatus
6083197, Dec 19 1995 Spring-actuated needleless injector
6210359, Jan 21 2000 Jet Medica, L.L.C.; JET MEDICA, L L C Needleless syringe
6270473, Mar 15 1995 Jettek, Inc. Hypodermic jet injector and disposable ampule
6471669, Mar 05 2001 BIOJECT INC Disposable needle-free injection apparatus and method
6537245, Oct 08 1999 Crossject Company Needleless syringe with a friction activated pyrotechnic initiator
6607510, Nov 09 2001 BIOJECT INC Disposable needle-free injection apparatus and method
6610042, Dec 05 1997 PULSE NEEDLEFREE SYSTEMS, INC Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
6626871, Oct 11 1999 PULSE NEEDLEFREE SYSTEMS, INC Method and apparatus for removing cap from medical device
6641554, Mar 05 2001 BIOJECT INC Disposable needle-free injection apparatus and method
6645170, Mar 05 2001 BIOJECT INC Simplified disposable needle-free injection apparatus and method
6666843, Nov 05 1999 CROSSJECT Needleless syringe with temporarily retained thrusting means
6676630, Jun 04 2002 BIOJECT INC Needle-free injection system
6758829, Apr 19 2000 CROSSJECT Needleless syringe functioning with a double-composition pyrotechnic charge
6770054, Nov 23 1999 PULSE NEEDLEFREE SYSTEMS, INC Injector assembly with driving means and locking means
6802826, Oct 12 1999 PULSE NEEDLEFREE SYSTEMS, INC Universal anti-infectious protector for needleless injectors
6835187, Feb 02 2000 CROSSJECT Needleless syringe provided with an inner seal containing the active principle
6837866, Dec 08 1999 CROSSJECT Needleless syringe provided with an ejection tube with a constant cross-section
6883222, Oct 16 2002 INOVIO PHARMACEUTICALS, INC Drug cartridge assembly and method of manufacture
6942638, May 30 2002 PHARMAJET, INC Needleless injector and ampule system
6942645, Mar 01 2000 CROSSJECT Needleless syringe with two injection speed levels
6951070, May 26 2000 PIEXON AG Defense device, preferably self-defense device and storage unit used therein
6960184, Dec 17 1999 VALERITAS, INC Injection devices
6964650, Oct 23 2000 CROSSJECT Needleless Safety Syringe of Compact Architecture
6979310, May 30 2000 CROSSJECT Needleless syringe with membrane isolating a multiple duct injector
7074210, Oct 10 2000 PULSE NEEDLEFREE SYSTEMS, INC Universal protector cap with auto-disable features for needle-free injectors
7150409, Nov 30 2000 VALERITAS, LLC Injection systems
7156822, May 30 2000 CROSSJECT Needleless syringe with membrane isolating a multiple duct injector
7238167, Jun 04 2002 BIOJECT INC Needle-free injection system
7261702, Jul 16 1999 CROSSJECT Needleless syringe operating with an impact wave generator through a wall
7316090, Nov 26 2002 PIEXON AG Defense device, preferably self-defense device and storage unit used therein
7320677, Oct 20 2000 SOCPRA SCIENCES ET GÉNIE S E C Needleless syringe for the delivery of therapeutic agents
7357780, Apr 19 2000 CROSSJECT Needleless syringe functioning with a double-composition pyrotechnic charge
7513885, May 29 2001 CROSSJECT Needleless syringe with membrane isolating a multiple duct injector
7547293, Oct 06 2006 INOVIO PHARMACEUTICALS, INC Triggering mechanism for needle-free injector
7618393, May 03 2005 PHARMAJET, INC Needle-less injector and method of fluid delivery
7699802, May 03 2005 PHARMAJET, INC Needle-less injector
7717874, May 28 2004 INOVIO PHARMACEUTICALS, INC Needle-free injection system
7740607, Dec 18 1998 VALERITAS, INC Modular units for use in an injection device
7744563, Feb 23 2007 BIOJECT INC Needle-free injection devices and drug delivery systems therefor
7806867, Jan 07 2000 VALERITAS, INC Injection device
7854720, May 28 2004 Bioject, Inc. Needle-free injection system
7887506, Nov 21 2000 PULSE NEEDLEFREE SYSTEMS, INC Safety mechanism to prevent accidental patient injection and methods of same
8070714, Jun 22 2000 CROSSJECT Needleless syringe provided with modular reservoir
8105272, Oct 06 2006 Bioject, Inc. Triggering mechanism for a needle-free injector
8480617, Dec 07 2005 PAINLESS TECH GMBH Injection device and ampoule unit
8500681, Nov 30 2000 VALERITAS, INC. Injection systems
8529500, May 03 2005 PHARMAJET, INC Needle-less injector and method of fluid delivery
8920367, Mar 29 2006 KALEO, INC Devices, systems and methods for medicament delivery
8920377, Nov 23 2004 KALEO, INC Devices, systems and methods for medicament delivery
8926594, Feb 01 2005 KALEO, INC Devices, systems and methods for medicament delivery
9056170, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
9084849, Jan 26 2011 KALEO, INC Medicament delivery devices for administration of a medicament within a prefilled syringe
9149579, Nov 23 2004 KALEO, INC Devices, systems and methods for medicament delivery
9173999, Jan 26 2011 KALEO, INC Devices and methods for delivering medicaments from a multi-chamber container
9238108, Feb 01 2005 KALEO, INC Medicament delivery device having an electronic circuit system
9259539, Feb 01 2005 kaleo, Inc. Devices, systems and methods for medicament delivery
9278177, Feb 01 2005 kaleo, Inc. Medical injector with compliance tracking and monitoring
9278182, Oct 31 2005 kaleo, Inc. Devices, systems and methods for medicament delivery
9327077, Feb 01 2005 KALEO, INC Medical injector with compliance tracking and monitoring
9333300, May 03 2005 PHARMAJET, INC. Needle-less injector and method of fluid delivery
9352091, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
9408972, Aug 02 2011 PHARMAJET, INC. Needle-free injection device
9433735, Dec 13 2011 PHARMAJET INC Needle-free intradermal injection device
9522235, May 22 2012 KALEO, INC Devices and methods for delivering medicaments from a multi-chamber container
9533098, Nov 19 2007 PAINLESS TECH GMBH Injection device for the needle-free injection of a medium
9700675, Dec 13 2011 Pharmajet Inc. Needle-free intradermal injection device
9724471, Oct 31 2005 kaleo, Inc. Devices, systems, and methods for medicament delivery
9737669, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
9805620, Feb 27 2007 kaleo, Inc. Medical injector simulation device
9833573, Nov 23 2004 kaleo, Inc. Devices, systems and methods for medicament delivery
9867938, Mar 29 2006 kaleo, Inc. Devices, systems and methods for medicament delivery
9968479, May 16 2007 Thomas John, Harkins, Jr. System and method for treating erectile dysfunction
ER3536,
ER3951,
ER9785,
Patent Priority Assignee Title
2322245,
2667874,
3802430,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
May 08 1992SCHWEBEL, PAUL R JETTEK, INC A CORP OF INDIANAASSIGNMENT OF ASSIGNORS INTEREST 0061390217 pdf
Date Maintenance Fee Events


Date Maintenance Schedule
Nov 07 19814 years fee payment window open
May 07 19826 months grace period start (w surcharge)
Nov 07 1982patent expiry (for year 4)
Nov 07 19842 years to revive unintentionally abandoned end. (for year 4)
Nov 07 19858 years fee payment window open
May 07 19866 months grace period start (w surcharge)
Nov 07 1986patent expiry (for year 8)
Nov 07 19882 years to revive unintentionally abandoned end. (for year 8)
Nov 07 198912 years fee payment window open
May 07 19906 months grace period start (w surcharge)
Nov 07 1990patent expiry (for year 12)
Nov 07 19922 years to revive unintentionally abandoned end. (for year 12)